Background And Objective: Endoscopic cyclophotocoagulation is a laser modality used to treat refractory glaucoma through the ablation of ciliary epithelium on the ciliary processes, which results in reduced aqueous production. The purpose of this study was to investigate the effect of various viscoelastics and optimal probe positioning on endoscopic cyclophotocoagulation treatment.

Materials And Methods: Six different viscoelastic materials and a balanced salt solution, which was used as a control, were evaluated by placing 2 mL of each in a separate 2 mL glass tube. Laser power was measured at six distances to represent clinical placement of the laser probe in relation to the ciliary processes.

Results: The amount of energy measured with the probe at the bottom of the tube and 1 and 2 mm away was not statistically significantly different among the viscoelastic materials or the balanced salt solution. There was a gradual decrease in transmission of laser energy in all viscoelastics as the laser probe was moved farther away.

Conclusion: To preserve the intended laser energy setting, the optimal distance between the treated tissue and the laser probe is 2 mm.

Download full-text PDF

Source
http://dx.doi.org/10.3928/15428877-20080301-18DOI Listing

Publication Analysis

Top Keywords

endoscopic cyclophotocoagulation
12
laser energy
12
laser probe
12
laser
8
cyclophotocoagulation laser
8
viscoelastic materials
8
materials balanced
8
balanced salt
8
salt solution
8
probe
6

Similar Publications

Article Synopsis
  • * Endoscopic cyclophotocoagulation (ECP) is a key treatment method that works by reducing the production of aqueous humor through the coagulation of the ciliary body, and has been in use since the 1990s.
  • * The review discusses the technology used in ECP, its effectiveness compared to other treatments, its current clinical use, possible postoperative complications, and how ECP’s role in glaucoma treatment is expected to grow and adapt with new advancements.
View Article and Find Full Text PDF
Article Synopsis
  • A 69-year-old Japanese woman with severe glaucoma and a history of multiple eye surgeries experienced corneal endothelial graft failure after having endoscopic cyclophotocoagulation (ECP) to manage high intraocular pressure (IOP).
  • She underwent two DSAEK procedures, with the second one initially successful but ultimately leading to graft failure after subsequent ECP treatment.
  • The case highlights the need for careful decision-making regarding ECP in patients with existing corneal endothelial issues.
View Article and Find Full Text PDF

Purpose: The Hydrus microstent was approved by the FDA in August 2018 for use with cataract surgery to reduce IOP in patients with mild to moderate primary open angle glaucoma (POAG). Pivotal clinical trials demonstrated its overall safety and efficacy in lowering IOP. However, malpositioning of the implant can result in uveitis-glaucoma-hyphema (UGH) syndrome necessitating device explantation.

View Article and Find Full Text PDF

Long-term efficacy and safety of posterior endoscopic cyclophotocoagulation in refractory glaucoma: A 5-year follow-up study at a tertiary eye center.

Asia Pac J Ophthalmol (Phila)

June 2024

Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Lab, Beijing 100730, China. Electronic address:

Purpose: To evaluate the long-term efficacy of endoscopic cyclophotocoagulation (ECP) via a pars plana approach in a large cohort of refractory glaucoma patients DESIGN: Single-center, retrospective, longitudinal, cohort study.

Methods: This study recruited patients who underwent ECP and consecutively visited and were followed up for at least 5 years at Beijing Tongren Eye Center, China from January 2013 to December 2017. All patients underwent a complete ophthalmic examination.

View Article and Find Full Text PDF

Age is an important risk factor for both glaucoma and cataract. As global life expectancy continues to rise, the prevalence of concomitant open-angle glaucoma (OAG) and cataracts is increasing. Currently, there is a lack of definitive consensus on the optimal management approach for such individuals.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!